ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

PHIO Phio Pharmaceuticals Corporation

0,81
0,0343 (4,42%)
Vor Marktöffnung
Zuletzt aktualisiert: 14:11:31
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Phio Pharmaceuticals Corporation PHIO NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,0343 4,42% 0,81 14:11:31
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,7757
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.4.202413:30GLOBEPhio Pharmaceuticals Announces Upcoming Presentation at the..
22.4.202419:10GLOBEIntratumoral Injection of Phio’s PH-762 significantly..
16.4.202413:30GLOBEPhio Pharmaceuticals Announces Upcoming Presentations at the..
11.4.202413:30GLOBEPhio Pharmaceuticals Announces Upcoming Presentation at the..
03.4.202413:30GLOBENational Spotlight Features Phio’s Innovative RNAi..
02.4.202413:30GLOBEPhio Pharmaceuticals Reports 2023 Year End Financial Results..
21.3.202412:30GLOBEPhio Pharmaceuticals Presenting Data Showing INTASYL May..
13.3.202419:00GLOBEPhio Pharmaceuticals Announces Addition of Clinical Trial..
06.3.202416:30GLOBEPhio Pharmaceuticals Announces Patent Granted by USPTO,..
06.3.202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202416:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31.1.202414:00GLOBEPhio Pharmaceuticals Announces Data Showing INTASYL May..
26.1.202423:00EDGAR2Form 8-K - Current report
28.12.202315:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28.12.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
19.12.202322:52EDGAR2Form S-1 - General form for registration of securities under..
08.12.202323:00EDGAR2Form 8-K - Current report
07.12.202314:00GLOBEPhio Pharmaceuticals Announces Exercise of Warrants for $2.8..
09.11.202322:40EDGAR2Form 8-K - Current report
09.11.202322:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202322:30GLOBEPhio Pharmaceuticals Reports Third Quarter 2023 Financial..
09.11.202313:30GLOBEPhio Pharmaceuticals Announces First US Patient Enrolled in..
03.11.202317:00GLOBEPhio Pharmaceuticals Presents New Data Showing INTASYL..
12.10.202317:00GLOBEPhio Pharmaceuticals Announces Upcoming Presentation at the..
11.10.202313:30GLOBEPhio Pharmaceuticals Presents New Data for Targeting of BRD4..
06.9.202313:30GLOBEPhio CEO to Speak at Wainwright Conference in New York in..
21.8.202313:30GLOBEPhio Pharmaceuticals Announces Dosing of First Patient in..
21.8.202313:30EDGAR2Form 8-K - Current report
10.8.202322:40EDGAR2Form 8-K - Current report
10.8.202322:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10.8.202322:30GLOBEPhio Pharmaceuticals Reports Second Quarter 2023 Financial..
26.7.202322:30EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

Delayed Upgrade Clock